AI assistant
Apotea AB — Share Issue/Capital Change 2026
May 29, 2026
10019_rns_2026-05-29_3c4ed217-8679-43b1-bc4d-272512f5be5a.pdf
Share Issue/Capital Change
Open in viewerOpens in your device viewer
Press Release
29 May 2026 07:30:00 CEST
apotea-se
Number of shares and votes in Apotea
Apotea has on 28 May, as part of the newly established D-share programme for employees and in accordance with the authorisation granted by the Annual General Meeting held on 26 May 2026, completed a directed new share issue of a total of 400,000 Class D shares.
As a result of the new share issue, the number of shares in Apotea has increased by 400,000 shares and the number of votes by 40,000 votes.
As of 29 May 2026, the total number of shares amounts to 105,665,254 distributed between 104,070,966 ordinary shares, 1,194,288 Class C shares and 400,000 Class D shares. Each ordinary share carries one (1) vote, while each Class C share and Class D share carries one tenth (1/10) of a vote. The total number of votes amounts to 104,230,394.80.
As a result of the newly issued Class D shares, Apotea's share capital has increased by SEK 2,000 from SEK 526,326.27 to SEK 528,326.27.
For further information, please contact:
Stefan Eriksson, deputy CEO & Investor Relations
E-mail: [email protected]
This information is information that Apotea is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for publication at 2026-05-29 07:30 CEST.
About Apotea
Apotea is Sweden's leading online pharmacy with the ambition to become the pharmacy of tomorrow by continuously simplifying and enhancing the customer experience. With the widest assortment on the market, low prices and fast deliveries, Apotea facilitates everyday life for over three million active customers. In E-barometern's 2025 customer survey, Apotea was ranked as the customers' favourite e-commerce store for the eighth consecutive year. Since 2022, the group also operates in Norway through its Norwegian subsidiary Apotera.
Apotea